Enterprise Bank & Trust CO Biogen Inc. Transaction History

Enterprise Bank & Trust CO

$302 Million
Q4 2024

A detailed history of Enterprise Bank & Trust CO transactions in Biogen Inc. stock. As of the latest transaction made, Enterprise Bank & Trust CO holds 2,864 shares of BIIB stock, worth $411,757. This represents 0.14% of its overall portfolio holdings.

Number of Shares

2,864

Previous 4,002 28.44%

Holding current value

$411,757

Previous $775,000 43.61%

% of portfolio

0.14%

Previous 0.25%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 13, 2025	SELL	$146.47 - $191.55 $166,682 - $217,983	-1,138 Reduced 28.44%	2,864 $437,000
Q3 2024 Oct 08, 2024	SELL	$189.07 - $236.8 $107,580 - $134,739	-569 Reduced 12.45%	4,002 $775,000
Q2 2024 Jul 10, 2024	SELL	$190.52 - $236.72 $9,335 - $11,599	-49 Reduced 1.06%	4,571 $1.06 Million
Q1 2024 Apr 10, 2024	BUY	$212.02 - $267.71 $848 - $1,070	4 Added 0.09%	4,620 $996,000
Q4 2023 Jan 09, 2024	SELL	$222.59 - $267.94 $8,681 - $10,449	-39 Reduced 0.84%	4,616 $1.19 Million
Q3 2023 Oct 16, 2023	BUY	$253.3 - $285.89 $13,931 - $15,723	55 Added 1.2%	4,655 $1.2 Million
Q2 2023 Jul 06, 2023	BUY	$275.25 - $318.06 $55,875 - $64,566	203 Added 4.62%	4,600 $1.31 Million
Q1 2023 Apr 11, 2023	BUY	$256.56 - $292.34 $1,795 - $2,046	7 Added 0.16%	4,397 $1.22 Million
Q4 2022 Jan 11, 2023	SELL	$252.44 - $306.72 $2,524 - $3,067	-10 Reduced 0.23%	4,390 $0
Q3 2022 Oct 06, 2022	BUY	$194.69 - $268.46 $27,256 - $37,584	140 Added 3.29%	4,400 $1.18 Million
Q2 2022 Jul 06, 2022	BUY	$187.54 - $223.02 $798,920 - $950,065	4,260 New	4,260 $869,000

Others Institutions Holding BIIB

# of Institutions

1,001

Shares Held

131M

Call Options Held

1.77M

Put Options Held

2.34M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Enterprise Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Enterprise Bank & Trust CO with notifications on news.

Account

Enterprise Bank & Trust CO Biogen Inc. Transaction History